Pharmacogenomics of statin therapy: any new insights in efficacy or safety?
PURPOSE OF REVIEW: To examine the current evidence concerning the effects of genetic variation on statin-related low-density lipoprotein cholesterol reductions, clinical efficacy, and adverse events and the relevance for patient care. RECENT FINDINGS: Recent years have seen the emergence of large-sc...
Päätekijät: | Hopewell, J, Reith, C, Armitage, J |
---|---|
Aineistotyyppi: | Journal article |
Kieli: | English |
Julkaistu: |
Lippincott Williams and Wilkins
2014
|
Samankaltaisia teoksia
-
Interpretation of the evidence for the efficacy and safety of statin therapy
Tekijä: Collins, R, et al.
Julkaistu: (2016) -
Safety and efficacy of statins - Authors' reply
Tekijä: Collins, R, et al.
Julkaistu: (2017) -
Efficacy and safety of statin therapy in older people: meta-analysis of individual participant data from 28 randomised controlled trials
Tekijä: Cholesterol Treatment Trialists' Collaboration, et al.
Julkaistu: (2019) -
Pharmacogenomics Statins: Biomarkers for Clinical Prediction
Tekijä: Herni Suprapti
Julkaistu: (2018-09-01) -
The safety of statins in clinical practice.
Tekijä: Armitage, J
Julkaistu: (2007)